Samantha McLemore Patient Capital Management
Samantha McLemore is the founder of Patient Capital Management and previously worked closely with Bill Miller on value-oriented strategies. Her firm emphasizes long-term, research-driven equity investing with a willingness to hold unconventional or out-of-favor ideas. McLemore’s portfolio is followed by investors who track the next generation of independent value managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$64.9M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$54M |
| 3 |
CHYM
Chime Financial
CHYM
|
+$23.3M |
| 4 |
Adobe
ADBE
|
+$15.1M |
| 5 |
Amazon
AMZN
|
+$6.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Noble Corp
NE
|
+$59.7M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$42.3M |
| 3 |
Illumina
ILMN
|
+$29.2M |
| 4 |
Biogen
BIIB
|
+$18.4M |
| 5 |
UBS Group
UBS
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.09% |
| 2 | Consumer Discretionary | 16.85% |
| 3 | Communication Services | 13.22% |
| 4 | Financials | 12.81% |
| 5 | Technology | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FISV
26
Fiserv Inc
FISV
$28B
| $46.8M | 1.53% |
953,637
-14,557
| -2% | -$814K |
|
27
Expedia Group
EXPE
$38.6B
| $42.9M | 1.41% |
167,814
+30
| +0% | +$7.13K |
|
28
OneMain Financial
OMF
$7.27B
| $42.8M | 1.4% |
702,369
-79,002
| -10% | -$4.45M |
|
|
29
CALL
Biogen
BIIB
$32B
| $40.9M | 1.34% |
189,400
+187,506
| +9,900% | +$35.9M |
|
30
Delta Air Lines
DAL
$54.2B
| $40.4M | 1.32% |
431,215
-121,299
| -22% | -$9.16M |
|
31
JD.com
JD
$39.7B
| $35.1M | 1.15% |
1,377,719
-21,749
| -2% | -$641K |
|
32
SoFi Technologies
SOFI
$24.4B
| $27M | 0.89% |
1,505,629
+179,383
| +14% | +$3.04M |
|
|
TEM
33
Tempus AI
TEM
$13.1B
| $23.2M | 0.76% |
400,698
-41,501
| -9% | -$2.08M |
|
34
JPMorgan Chase
JPM
$935B
| $9.61M | 0.32% |
29,360
-2
| -0% | -$621 |
|
35
Genius Sports
GENI
$2.16B
| $4.93M | 0.16% |
+812,819
| New | +$4.21M |
|
|
36
Noble Corp
NE
$7.39B
| $3.73M | 0.12% |
100,000
-1,247,854
| -93% | -$59.7M |
|
37
Dave & Buster's
PLAY
$357M
| $2.33M | 0.08% |
204,022
-947,636
| -82% | -$11.3M |
|
38
APA Corp
APA
$15.2B
| $1.63M | 0.05% |
50,000
| – | – |
|
39
Lennar Class B
LEN.B
$20.6B
| $1.11M | 0.04% |
12,500
| – | – |
|
40
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $792K | 0.03% |
1,060
-55
| -5% | -$39.9K |
|
|
41
iShares Bitcoin Trust
IBIT
$57.7B
| – | – |
-1,100,000
| Closed | -$42.3M |
|
42
PUT
Tesla
TSLA
$1.43T
| – | – |
-500
| Closed | -$18.6M |
|
Similar funds
Samantha McLemore's Q2 2026 Portfolio in Review
As of Q2 2026, Samantha McLemore held 42 positions worth $3.05B, up 12% from $2.74B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Samantha McLemore's Q2 2026 filing shows 2 new, 12 increased, 24 reduced and 2 closed positions. Its largest new stake was Global Payments: 942,310 shares worth $68.4M. The largest sale was Noble Corp, an estimated $59.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Samantha McLemore's largest Q2 2026 buy was Global Payments: 942,310 shares worth $68.4M.
- Samantha McLemore added most to Fidelity Wise Origin Bitcoin Fund in Q2 2026, an estimated $54M increase.
- Samantha McLemore's biggest Q2 2026 reduction was Noble Corp, cutting an estimated $59.7M.
- Samantha McLemore fully exited iShares Bitcoin Trust in Q2 2026, selling an estimated $42.3M.
- Samantha McLemore's ten largest holdings make up 51% of its $3.05B portfolio in Q2 2026.
- Samantha McLemore opened 2 new positions and closed 2 in Q2 2026.
- Samantha McLemore's portfolio value rose 12% quarter-over-quarter to $3.05B.
Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.